Spectrum Pharmaceutecals Inc (SPPI)

[Phoenix300]

JMP Securities Thinks Spectrum Pharmaceuticals’ Stock is Going to Recover

Source: TipRanks
In a report released today, Reni Benjamin from JMP Securities reiterated a Buy rating on Spectrum Pharmaceuticals (SPPI – Research Report), with a price target of $4.00. The company's shares closed last Friday at $0.90, close to its 52-week low of $0.60. According to TipRanks.com, Benjamin is ranked 0 out of 5 stars with an average return of -9.2% and a 35.4% success rate. Benjamin covers the Healthcare sector, focusing on stocks such as Deciphera Pharmaceuticals, Iovance Biotherapeutics, and Allogene Therapeutics. Currently, the analyst consensus on Spectrum Pharmaceuticals is a Strong Buy with an average price target of $6.00, representing a 609.4% upside.
https://www.tipranks.com/news/blurbs/jmp-securities-thinks-spectrum-pharmaceuticals-stock-is-going-to-recover-3?utm_source=advfn.com&utm_medium=referral